Stoppa-Lyonnet D - Search Results

1

EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients.

Caux-Moncoutier V, Castéra L, Tirapo C, Michaux D, Rémon MA, Laugé A, Rouleau E, De Pauw A, Buecher B, Gauthier-Villars M, Viovy JL, Stoppa-Lyonnet D, Houdayer C. Caux-Moncoutier V, et al. Hum Mutat. 2011 Mar;32(3):325-34. doi: 10.1002/humu.21414. Epub 2011 Feb 8. Hum Mutat. 2011. PMID: 21120943

2

BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.

Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pagès S, Ithier G, Ligot L, Fourquet A, Salmon RJ, Clough KB, Pouillart P, Bonaïti-Pellié C, Thomas G. Stoppa-Lyonnet D, et al. Am J Hum Genet. 1997 May;60(5):1021-30. Am J Hum Genet. 1997. PMID: 9150149 Free PMC article.

3

Inactivation of the ATM gene in T-cell prolymphocytic leukemias.

Stoppa-Lyonnet D, Soulier J, Laugé A, Dastot H, Garand R, Sigaux F, Stern MH. Stoppa-Lyonnet D, et al. Blood. 1998 May 15;91(10):3920-6. Blood. 1998. PMID: 9573030 Free article.

4

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.

Janin N, Andrieu N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D. Janin N, et al. Br J Cancer. 1999 Jun;80(7):1042-5. doi: 10.1038/sj.bjc.6690460. Br J Cancer. 1999. PMID: 10362113 Free PMC article.

5

No evidence for germline PTEN mutations in families with breast and brain tumours.

Laugé A, Lefebvre C, Laurent-Puig P, Caux V, Gad S, Eng C, Longy M, Stoppa-Lyonnet D. Laugé A, et al. Int J Cancer. 1999 Jun 21;84(3):216-9. doi: 10.1002/(sici)1097-0215(19990621)84:3<216::aid-ijc3>3.0.co;2-e. Int J Cancer. 1999. PMID: 10371336

6

Genetic testing for breast cancer predisposition.

Gauthier-Villars M, Gad S, Caux V, Pagès S, Blandy C, Stoppa-Lyonnet D. Gauthier-Villars M, et al. Surg Clin North Am. 1999 Oct;79(5):1171-87, xxi. doi: 10.1016/s0039-6109(05)70067-0. Surg Clin North Am. 1999. PMID: 10572557 Review.

7

[Under what conditions should we propose a prophylactic mastectomy for a woman at risk?].

Gauthier-Villars M, Blandy C, Stoppa-Lyonnet D. Gauthier-Villars M, et al. Bull Cancer. 1999 Sep;86(9):754-9. Bull Cancer. 1999. PMID: 10576812 Free article. French. No abstract available.

8

Familial invasive breast cancers: worse outcome related to BRCA1 mutations.

Stoppa-Lyonnet D, Ansquer Y, Dreyfus H, Gautier C, Gauthier-Villars M, Bourstyn E, Clough KB, Magdelénat H, Pouillart P, Vincent-Salomon A, Fourquet A, Asselain B. Stoppa-Lyonnet D, et al. J Clin Oncol. 2000 Dec 15;18(24):4053-9. doi: 10.1200/JCO.2000.18.24.4053. J Clin Oncol. 2000. PMID: 11118466

9

Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons.

Pages S, Caux V, Stoppa-Lyonnet D, Tosi M. Pages S, et al. Br J Cancer. 2001 Feb;84(4):482-8. doi: 10.1054/bjoc.2000.1627. Br J Cancer. 2001. PMID: 11207042 Free PMC article.

10

Color bar coding the BRCA1 gene on combed DNA: a useful strategy for detecting large gene rearrangements.

Gad S, Aurias A, Puget N, Mairal A, Schurra C, Montagna M, Pages S, Caux V, Mazoyer S, Bensimon A, Stoppa-Lyonnet D. Gad S, et al. Genes Chromosomes Cancer. 2001 May;31(1):75-84. doi: 10.1002/gcc.1120. Genes Chromosomes Cancer. 2001. PMID: 11284038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

491 results

Search Page